secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001731122-23-001396
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro raises $2M in private placement; converts $2M debt into equity
-----------------------------------------------------------------------

- Issued 280,005 units at $7.13/unit for $2M cash; each unit = 1 Series A Convertible Preferred share + warrant for 5 common shares.
- Converted $2M of promissory note into 280,505 units on same terms, leaving $3M note outstanding.
- Preferred stock convertible into common at 10:1; warrants exercisable at $0.65/share for 5 years.
- Offering under Regulation S, no underwriter; proceeds for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112223001396/0001731122-23-001396-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112223001396/e4889_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-23-001396

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer